Literature DB >> 32439311

Therapeutic aspects of AMPK in breast cancer: Progress, challenges, and future directions.

Lavanya Ponnusamy1, Sathan Raj Natarajan1, Karthik Thangaraj1, Ravi Manoharan2.   

Abstract

Breast cancer is the most ubiquitous type of neoplasms among women worldwide. Molecular aberrations associated with breast development and progressions have been extensively investigated in recent years. An AMP-activated kinase (AMPK) initially identified as a cellular energy sensor that plays a crucial role in cellular energy homeostasis. Intensive research over the last decade about the molecular mechanisms of AMPK has demonstrated that AMPK mediated diverse biological functions are achieved through phosphorylation and regulation of multiple downstream signaling molecules in normal tissue. Downregulation of AMPK activity or decreased level involved in the promotion of breast tumorigenesis, and thus activation of AMPK found to oppose tumor progression. In this review, we epitomize the recent advances in exploring the tumor suppressor function of AMPK pathways. Besides, we discuss the developments in the area of AMPK activator and its molecular mechanisms for breast cancer treatment.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AMPK; AMPK activator; Breast cancer; Natural compounds; Synthetic compounds

Year:  2020        PMID: 32439311     DOI: 10.1016/j.bbcan.2020.188379

Source DB:  PubMed          Journal:  Biochim Biophys Acta Rev Cancer        ISSN: 0304-419X            Impact factor:   10.680


  9 in total

1.  Design of Hybrid Polymeric-Lipid Nanoparticles Using Curcumin as a Model: Preparation, Characterization, and In Vitro Evaluation of Demethoxycurcumin and Bisdemethoxycurcumin-Loaded Nanoparticles.

Authors:  Krissia Wilhelm Romero; María Isabel Quirós; Felipe Vargas Huertas; José Roberto Vega-Baudrit; Mirtha Navarro-Hoyos; Andrea Mariela Araya-Sibaja
Journal:  Polymers (Basel)       Date:  2021-11-30       Impact factor: 4.329

Review 2.  Inhibiting the Priming for Cancer in Li-Fraumeni Syndrome.

Authors:  Pan Pantziarka; Sarah Blagden
Journal:  Cancers (Basel)       Date:  2022-03-23       Impact factor: 6.639

Review 3.  Apoptosis Induction, a Sharp Edge of Berberine to Exert Anti-Cancer Effects, Focus on Breast, Lung, and Liver Cancer.

Authors:  Yi Zhu; Na Xie; Yilu Chai; Yisen Nie; Ke Liu; Yufei Liu; Yang Yang; Jinsong Su; Chuantao Zhang
Journal:  Front Pharmacol       Date:  2022-01-27       Impact factor: 5.810

Review 4.  Therapeutic Potential for Targeting Autophagy in ER+ Breast Cancer.

Authors:  Ryan M Finnegan; Ahmed M Elshazly; Patricia V Schoenlein; David A Gewirtz
Journal:  Cancers (Basel)       Date:  2022-09-01       Impact factor: 6.575

Review 5.  Berberine as a potential agent for breast cancer therapy.

Authors:  Xiao-Dan Zhong; Li-Juan Chen; Xin-Yang Xu; Yan-Jun Liu; Fan Tao; Ming-Hui Zhu; Chang-Yun Li; Dan Zhao; Guan-Jun Yang; Jiong Chen
Journal:  Front Oncol       Date:  2022-09-02       Impact factor: 5.738

6.  Using machine learning to identify gene interaction networks associated with breast cancer.

Authors:  Liyuan Liu; Wenli Zhai; Fei Wang; Lixiang Yu; Fei Zhou; Yujuan Xiang; Shuya Huang; Chao Zheng; Zhongshang Yuan; Yong He; Zhigang Yu; Jiadong Ji
Journal:  BMC Cancer       Date:  2022-10-17       Impact factor: 4.638

Review 7.  The AMPK pathway in fatty liver disease.

Authors:  Chunqiu Fang; Jianheng Pan; Ning Qu; Yuting Lei; Jiajun Han; Jingzhou Zhang; Dong Han
Journal:  Front Physiol       Date:  2022-08-25       Impact factor: 4.755

Review 8.  Cancer-associated adipocytes: emerging supporters in breast cancer.

Authors:  Chongru Zhao; Min Wu; Ning Zeng; Mingchen Xiong; Weijie Hu; Wenchang Lv; Yi Yi; Qi Zhang; Yiping Wu
Journal:  J Exp Clin Cancer Res       Date:  2020-08-12

Review 9.  Current Landscape: The Mechanism and Therapeutic Impact of Obesity for Breast Cancer.

Authors:  Chongru Zhao; Weijie Hu; Yi Xu; Dawei Wang; Yichen Wang; Wenchang Lv; Mingchen Xiong; Yi Yi; Haiping Wang; Qi Zhang; Yiping Wu
Journal:  Front Oncol       Date:  2021-07-19       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.